Addeo R, Caraglia M, Vincenzi B, Luce A, Montella L, Mastella A, Mazzone S, Ricciardiello F, Carraturo M, Del Prete S, Sperlongano P (2019) Efficacy and safety of cetuximab plus radiotherapy in cisplatin-unfit elderly patients with advanced squamous cell head and neck carcinoma a retrospective study. Chemotherapy 64(1):48–56. https://doi.org/10.1159/000500714

Article  CAS  PubMed  Google Scholar 

Agarwal JP, Gupta T, Budrukkar NA, Laskar SG, Murthy V, Kumar P, Narohna V, Pai P, Chaturvedi P, Dcruz AK (2011) Cetuximab with radiotherapy in patients with loco-regionally advanced squamous cell carcinoma of head and neck unsuitable or ineligible for concurrent platinum-based chemo-radiotherapy: Ready for routine clinical practice. Indian J Cancer 48(2):148–153. https://doi.org/10.4103/0019-509X.82872

Article  CAS  PubMed  Google Scholar 

Ang KK (2008) Multidisciplinary management of locally advanced SCCHN: optimizing treatment outcomes. Oncologist 13(8):899–910. https://doi.org/10.1634/theoncologist.2007-0157

Article  CAS  PubMed  Google Scholar 

Barabas K, Milner R, Lurie D, Adin C (2008) Cisplatin: a review of toxicities and therapeutic applications. Vet Comp Oncol 6(1):1–18. https://doi.org/10.1111/j.1476-5829.2007.00142.x

Article  CAS  PubMed  Google Scholar 

Barsouk A, Aluru JS, Rawla P, Saginala K, Barsouk A (2023) Epidemiology, risk factors, and prevention of head and neck squamous cell carcinoma. Med Sci 11(2):42. https://doi.org/10.3390/medsci11020042

Article  CAS  Google Scholar 

Beckham TH, Barney C, Healy E, Wolfe AR, Branstetter A, Yaney A, Riaz N, McBride SM, Tsai CJ, Kang J, Yu Y, Chen L, Sherman E, Dunn L, Pfister DG, Tan J, Rupert R, Bonomi M, Zhang Z, Bhatt AD (2020) Platinum-based regimens versus cetuximab in definitive chemoradiation for human papillomavirus-unrelated head and neck cancer. Int J Cancer 147(1):107–115. https://doi.org/10.1002/ijc.32736

Article  CAS  PubMed  Google Scholar 

Bonner JA, Harari PM, Giralt J, Azarnia N, Shin DM, Cohen RB, Jones CU, Sur R, Raben D, Jassem J, Ove R, Kies MS, Baselga J, Youssoufian H, Amellal N, Rowinsky EK, Ang KK (2006) Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 354(6):567–578. https://doi.org/10.1056/NEJMoa053422

Article  CAS  PubMed  Google Scholar 

Burtness B, Harrington KJ, Greil R, Soulières D, Tahara M, De Castro G, Psyrri A, Basté N, Neupane P, Bratland Å, Fuereder T, Hughes BGM, Mesía R, Ngamphaiboon N, Rordorf T, Wan Ishak WZ, Hong R-L, González Mendoza R, Roy A, Yorio J (2019) Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study. Lancet 394(10212):1915–1928. https://doi.org/10.1016/S0140-6736(19)32591-7

Article  CAS  PubMed  Google Scholar 

Corry J, Bressel M, Fua T, Herschtal A, Solomon B, Porceddu SV, Wratten C, Rischin D (2017) Prospective study of cetuximab, carboplatin, and radiation therapy for patients with locally advanced head and neck squamous cell cancer unfit for cisplatin. Int J Radiat Oncol Biol Phys 98(4):948–954. https://doi.org/10.1016/j.ijrobp.2017.02.088

Article  CAS  PubMed  Google Scholar 

De Felice F, Tombolini V, De Vincentiis M, Magliulo G, Greco A, Valentini V, Polimeni A (2019) Multidisciplinary team in head and neck cancer: amanagement model. Med Oncol 36(1):2. https://doi.org/10.1007/s12032-018-1227-z

Article  Google Scholar 

De Ruysscher D, Niedermann G, Burnet NG, Siva S, Lee AWM, Hegi-Johnson F (2019) Radiotherapy toxicity. Nat Rev Dis Prim 5(1):13. https://doi.org/10.1038/s41572-019-0064-5

Article  PubMed  Google Scholar 

Dhull AK, Atri R, Dhankhar R, Chauhan AK, Kaushal V (2018) Major risk factors in head and neck cancer a retrospective analysis of 12-year experiences. World J Oncol 9(3):80–84. https://doi.org/10.14740/wjon1104w

Article  PubMed  PubMed Central  Google Scholar 

Espeli V, Zucca E, Ghielmini M, Giannini O, Salatino A, Martucci F, Richetti A (2012) Weekly and 3-weekly cisplatin concurrent with intensity-modulated radiotherapy in locally advanced head and neck squamous cell cancer. Oral Oncol 48(3):266–271. https://doi.org/10.1016/j.oraloncology.2011.10.005

Article  CAS  PubMed  Google Scholar 

Faltinsen EG, Storebø OJ, Jakobsen JC, Boesen K, Lange T, Gluud C (2018) Network meta-analysis: the highest level of medical evidence? BMJ Evid-Based Med 23(2):56–59. https://doi.org/10.1136/bmjebm-2017-110887

Article  PubMed  Google Scholar 

Fung AS, Afzal A, Banerjee R, Debenham B, Hao D (2020) A real-world comparison of cisplatin versus cetuximab used concurrently with radiation in the treatment of locally advanced oropharyngeal carcinoma: updated results. Curr Oncol 27(4):e416

Google Scholar 

Haddad RI, Harrington K, Tahara M, Szturz P, Le Tourneau C, Salmio S, Bajars M, Lee NY (2023) Managing cisplatin-ineligible patients with resected, high-risk, locally advanced squamous cell carcinoma of the head and neck: Is there a standard of care? Cancer Treat Rev 119:102585. https://doi.org/10.1016/j.ctrv.2023.102585

Article  CAS  PubMed  Google Scholar 

Hamauchi S, Yokota T, Mizumachi T, Onozawa Y, Ogawa H, Onoe T, Kamijo T, Iida Y, Nishimura T, Onitsuka T, Yasui H, Homma A (2019) Safety and efficacy of concurrent carboplatin or cetuximab plus radiotherapy for locally advanced head and neck cancer patients ineligible for treatment with cisplatin. Int Clin Oncol 24(5):468–475. https://doi.org/10.1007/s10147-018-01392-9

Article  CAS  Google Scholar 

Han J, Zakeri K, Raab G, Hesse J, Shamseddine A, Chen L, Yu Y, Kang JJ, McBride SM, Riaz N, Tsai CJ, Gelblum D, Sherman EJ, Wong RJ, Michel L, Lee NY (2023) Concurrent carboplatin and paclitaxel definitive radiation therapy for locally advanced head and neck cancer. Head Neck. https://doi.org/10.1002/hed.27456

Article  PubMed  PubMed Central  Google Scholar 

Imai C, Saeki H, Yamamoto K, Ichikawa A, Arai M, Tawada A, Suzuki T, Takiguchi Y, Hanazawa T, Ishii I (2022) Radiotherapy plus cetuximab for locally advanced squamous cell head and neck cancer in patients with cisplatin-ineligible renal dysfunction: a retrospective study. Oncol Lett. https://doi.org/10.3892/ol.2022.13271

Article  PubMed  PubMed Central  Google Scholar 

Kim SS, Liu HC, Mell LK (2023) Treatment considerations for patients with locoregionally advanced head and neck cancer with a contraindication to cisplatin. Curr Treat Options Oncol 24(3):147–161. https://doi.org/10.1007/s11864-023-01051-w

Article  PubMed  PubMed Central  Google Scholar 

Koyfman SA, Ismaila N, Crook D, D’Cruz A, Rodriguez CP, Sher DJ, Silbermins D, Sturgis EM, Tsue TT, Weiss J, Yom SS, Holsinger FC (2019) Management of the neck in squamous cell carcinoma of the oral cavity and oropharynx: ASCO clinical practice guideline. J Clin Oncol 37(20):1753–1774. https://doi.org/10.1200/JCO.18.01921

Article  PubMed  PubMed Central  Google Scholar 

Machiels J-P, René Leemans C, Golusinski W, Grau C, Licitra L, Gregoire V (2020) Squamous cell carcinoma of the oral cavity, larynx, oropharynx and hypopharynx: EHNS–ESMO–ESTRO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 31(11):1462–1475. https://doi.org/10.1016/j.annonc.2020.07.011

Article  PubMed  Google Scholar 

Magnes T, Wagner SM, Melchardt T, Weiss L, Rinnerthaler G, Huemer F, Kopp M, Gampenrieder SP, Mayrbäurl B, Füreder T, Lenger D, Andel J, Egle A, Greil R (2021) Postoperative chemoradiotherapy with cisplatin is superior to radioimmunotherapy with cetuximab and radiotherapy alone: analysis of the Austrian head and neck cancer registry of the AGMT. Wien Klin Wochenschr 133(21–22):1131–1136. https://doi.org/10.1007/s00508-021-01939-3

Article  CAS  PubMed  PubMed Central  Google Scholar 

Maring S, Elsayad K, Stenner M, Rudack C, Haverkamp U, Rehkämper J, Wardelmann E, Eich HT (2018) Efficacy of carboplatin/paclitaxel-based radiochemotherapy in locally advanced squamous cell carcinoma of head and neck. Oncol Res Treat 41(12):736–742. https://doi.org/10.1159/000494031

Article  CAS  PubMed  Google Scholar 

Nassif S, Wichmann J, Strube D, Vassis S, Christiansen H, Steinmann D (2022) Cisplatin versus carboplatin and paclitaxel in radiochemotherapy for patients with locally advanced head and neck squamous cell carcinoma. In Vivo (athens, Greece) 36(2):821–832. https://doi.org/10.21873/invivo.12769

Article  CAS  PubMed  Google Scholar 

NCCN Clinical Practice Guidelines in Oncology. Head and neck cancer. (n.d.). Retrieved December 6, 2023, from https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1437

Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hróbjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, Moher D (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. https://doi.org/10.1136/bmj.n71

Article  PubMed  PubMed Central